Cargando…
P3 mAb: An Immunogenic Anti-NeuGcGM3 Antibody with Unusual Immunoregulatory Properties
P3 is a murine IgM mAb that recognize N-glycosylated gangliosides, sulfatides, and antigens expressed in melanoma, breast, and lung human tumors. This antibody has the ability to trigger an IgG antibody response in the syngeneic BALB/c model, even when it is administered in the absence of adjuvant o...
Autores principales: | Martínez, Darel, Rodríguez, Nely, Griñán, Tania, Rondón, Teresa, Vázquez, Ana María, Pérez, Rolando, Hernández, Ana María |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Research Foundation
2012
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3342266/ https://www.ncbi.nlm.nih.gov/pubmed/22566972 http://dx.doi.org/10.3389/fimmu.2012.00094 |
Ejemplares similares
-
Frequent co-expression of EGFR and NeuGcGM3 ganglioside in cancer: it’s potential therapeutic implications
por: Palomo, Addys González, et al.
Publicado: (2016) -
Anti-ganglioside antibodies induced in chickens by an alum-adsorbed anti-idiotype antibody targeting NeuGcGM3
por: Guthmann, Marcelo D., et al.
Publicado: (2013) -
Prognostic Significance of Tumor Tissue NeuGcGM3 Ganglioside Expression in Patients Receiving Racotumomab Immunotherapy
por: Uskent, Necdet, et al.
Publicado: (2020) -
Human B-1 cells are important contributors to the naturally-occurring IgM pool against the tumor-associated ganglioside Neu5GcGM3
por: Rodriguez-Zhurbenko, Nely, et al.
Publicado: (2022) -
Structure of the immunoregulatory sialidase NEU1
por: Gorelik, Alexei, et al.
Publicado: (2023)